HCAQ

NASDAQ

HealthCor Catalio Acquisition Corp.

$10.84+0.42 (+4.03%)

News25/Ratings0

HealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.

Latest news

25 items

1578dINSIDER
SEC Form 4: Hc Sponsor Llc converted options into 5,534,000 shares and was granted 1,000,000 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Hughes Mark A. was granted 19,615 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4 filed by Siddiqui Khan
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Rothberg Jonathan M was granted 1,242,096 shares and was granted 15,055,288 units of Class B Common Stock
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4 filed by Scott David D
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Wolterman Dan was granted 16,483 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Fattori Ruth A was granted 17,374 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4 filed by Paykel Neela
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Huennekens R Scott was granted 16,483 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Sainz Maria was granted 16,483 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 4: Dahldorf John T was granted 16,483 shares
4 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider White Scott A.
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Dahldorf John T
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Siddiqui Khan
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Huennekens R Scott
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Fattori Ruth A
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Rothberg Jonathan M
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Paykel Neela
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Wolterman Dan
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Sainz Maria
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Scott David D
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Hughes Mark A.
3 - Hyperfine, Inc. (0001833769) (Issuer)
1582dINSIDER
SEC Form 3 filed by new insider Gupta Alok
3 - Hyperfine, Inc. (0001833769) (Issuer)
1583dPR
Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market
GUILFORD, Conn., Dec. 22, 2021 /PRNewswire/ -- Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it has completed its business combination with HealthCor Catalio Acquisition Corp. (NASDAQ:HCAQ) ("HealthCor"), a special purpose acquisition company sponsored by leading healthcare funds HealthCor Management, L.P. and Catalio Capital Management, LP, and Liminal Sciences, Inc. ("Liminal"), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain. Hyperfine will receive approximately $160 million in gross cash proceeds from the business combination
1585dSEC
SEC Form S-4MEF filed by HealthCor Catalio Acquisition Corp.
S-4MEF - HealthCor Catalio Acquisition Corp. (0001833769) (Filer)